PTC Therapeutics Inc (PTCT) Insider Trading

Total insider buys:
  • $31,673,582.00
Total insider sells:
  • $179,522,421.48
Most recent insider trade:
  • April 6, 2026
Most active insider trader:
  • Mark Elliott Boulding
Trader NameDateTitleAmountPriceTypeTotal Value
April 19, 2022COO897$42.52Sell$38,140.44
April 19, 2022Insider822$42.52Sell$34,951.44
April 14, 2022CEO82$45.28Sell$3,712.96
April 13, 2022VP2,276$45.17Sell$102,806.92
April 5, 2022VP5$45.00Sell$225.00
March 31, 2022CFO7,910$37.78Sell$298,839.80
Feb. 10, 2022VP17,935$45.03Sell$807,613.05
Feb. 1, 2022Insider367$40.00Sell$14,680.00
Feb. 1, 2022CAO313$40.00Sell$12,520.00
Feb. 1, 2022CEO1,961$40.00Sell$78,440.00
Feb. 1, 2022VP779$40.00Sell$31,160.00
Feb. 1, 2022CFO553$40.00Sell$22,120.00
Jan. 25, 2022CEO330$39.31Sell$12,972.30
Jan. 25, 2022Insider359$39.31Sell$14,112.29
Jan. 25, 2022CFO211$39.31Sell$8,294.41
Jan. 18, 2022CAO11,428$43.94Sell$502,146.32
Jan. 7, 2022Insider756$38.52Sell$29,121.12
Jan. 7, 2022CFO800$38.52Sell$30,816.00
Jan. 7, 2022CAO747$38.52Sell$28,774.44
Jan. 7, 2022VP885$38.52Sell$34,090.20
Jan. 4, 2022Insider64$41.16Sell$2,634.24
Jan. 4, 2022CEO378$41.16Sell$15,558.48
Jan. 4, 2022CFO173$41.16Sell$7,120.68
Aug. 13, 2021Director1,650$40.06Sell$66,099.00
July 8, 2021VP7,805$45.22Sell$352,942.10
June 9, 2021Director365$41.88Sell$15,286.20
April 19, 2021Insider786$48.17Sell$37,861.62
Feb. 1, 2021CFO541$56.96Sell$30,815.36
Feb. 1, 2021CAO368$56.96Sell$20,961.28
Feb. 1, 2021CAO368$56.96Sell$20,961.28
Feb. 1, 2021Director506$56.96Sell$28,821.76
Feb. 1, 2021VP778$56.96Sell$44,314.88
Feb. 1, 2021Insider973$56.96Sell$55,422.08
Feb. 1, 2021CEO1,968$56.96Sell$112,097.28
Jan. 25, 2021CFO275$62.05Sell$17,063.75
Jan. 25, 2021Insider541$63.15Sell$34,164.15
Jan. 25, 2021CEO350$62.05Sell$21,717.50
Jan. 15, 2021Insider4,300$69.09Sell$297,087.00
Jan. 8, 2021CFO26,033$69.75Sell$1,815,801.75
Jan. 7, 2021Insider3,886$68.98Sell$268,056.28
Jan. 5, 2021CEO1,402$62.37Sell$87,442.74
Jan. 5, 2021CAO316$62.37Sell$19,708.92
Jan. 5, 2021CFO288$62.37Sell$17,962.56
Jan. 5, 2021insider1,067$62.37Sell$66,548.79
Jan. 5, 2021VP772$62.37Sell$48,149.64
Dec. 30, 2020CEO285,718$61.74Sell$17,640,229.32
Dec. 8, 2020Director687$62.52Sell$42,951.24
Dec. 7, 2020CEO348,417$61.00Sell$21,253,437.00
Nov. 4, 2020CEO49,365$60.00Sell$2,961,900.00
Nov. 4, 2020CAO31,758$60.06Sell$1,907,385.48
  • Insiders are both buying and selling PTC Therapeutics Inc stock.

  • The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, Lee Scott Golden, Stephanie Okey, David P Southwell, Claudia De Oliveira Ri Hirawat, Pierre Gravier, Marcio Souza, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda

  • The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 34 trades.

  • Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.

  • Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.

  • The most recent insider trade for PTC Therapeutics Inc was on April 6, 2026.

  • The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.

  • The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.